A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors.Giuseppe Giaccone, Herbert M. Pinedo, Marlies Peters et al.|PubMed|2002Cited by 507
Activity and toxicity of GI147211 in breast, colorectal and non-small-cell lung cancer patients: An EORTC—ECSG phase II clinical studyTeresa Gamucci, A.-R. Hanauske, R Paridaens et al.|Annals of Oncology|2000Cited by 26